Literature DB >> 6697565

Idiotypic network: possible explanation of seronegativity in a patient with rheumatoid arthritis.

J L Pasquali, A Urlacher, D Storck.   

Abstract

In order to explain long term seronegativity in certain patients with rheumatoid arthritis (RA), we looked for the presence of anti-idiotypic antibodies against rheumatoid factors (RFs). From a patient's serum with classical but seronegative RA, we isolated a low quantity of the IgG fraction which partially recognized polyclonal RF idiotypes. The purified Fab'2 anti-idiotypic antibodies were able to inhibit up to 48% of in vitro RF production by pokeweed mitogen stimulated lymphocytes from a patient's peripheral blood with seropositive RA. The two main conclusions of this study are: (1) this single patient with seronegative RA has serum antibodies directed against RF idiotypes and (2) these anti-idiotypic antibodies could be implicated in the generation of seronegativity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6697565      PMCID: PMC1535810     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Cellular requirements for pokeweed mitogen-induced autoantibody production rheumatoid arthritis.

Authors:  C D Tsoukas; D A Carson; S Fong; J L Pasquali; J H Vaughan
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

2.  Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen.

Authors:  R S Geha
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

3.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

4.  Radioimmunoassay of IgG and IgM rheumatoid factors reacting with human IgG.

Authors:  D A Carson; S Lawrance; M A Catalano; J H Vaughan; G Abraham
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

5.  Specific suppression of the antibody response by antibodies to receptors.

Authors:  H Cosenza; H Köhler
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

6.  Regulation of monoclonal immunoglobulin G synthesis by antiidiotypic antibody in a patient with hypogammaglobulinemia.

Authors:  F Mudawwar; Z Awdeh; K Ault; R S Geha
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Inheritance of immunoglobulin M rheumatoid-factor idiotypes.

Authors:  J L Pasquali; S Fong; C Tsoukas; J H Vaughan; D A Carson
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

8.  Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.

Authors:  D Geltner; E C Franklin; B Frangione
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  Autoregulation of an antibody response via network-induced auto-anti-idiotype.

Authors:  J C Brown; L S Rodkey
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

10.  Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells.

Authors:  A F Schrater; E A Goidl; G J Thorbecke; G W Siskind
Journal:  J Exp Med       Date:  1979-07-01       Impact factor: 14.307

View more
  10 in total

1.  The specificity of human autoantibodies to IgG: the development of methodology for measuring the specificity of antiglobulin isotypes in rheumatoid and normal sera.

Authors:  R E March; V R Winrow; E J Holborow
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

Review 2.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

3.  Monoclonal antibodies defining a minor and a private idiotope on human rheumatoid factors.

Authors:  J L Pasquali; D Storck
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

Review 4.  Idiotypes and the structural diversity of human rheumatoid factors.

Authors:  S Fong; P P Chen; J J Crowley; G J Silverman; D A Carson
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Spontaneous reversal of acquired autoimmune dysfibrinogenemia probably due to an antiidiotypic antibody directed to an interspecies cross-reactive idiotype expressed on antifibrinogen antibodies.

Authors:  A Ruiz-Arguelles
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

6.  Demonstration of anti-idiotypic antibodies directed against IgM rheumatoid factor in the serum of rheumatoid arthritis patients.

Authors:  W K Hancock; E V Barnett
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Differences in anti-Fab antibodies in adult and late onset rheumatoid arthritis.

Authors:  F Gamerith; G J Zlabinger; O Scherak; G Kolarz; M Schemper; H Heinzl; J E Menzel
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

8.  Heterogeneity of anti-idiotypic antibodies to anti-DNA antibodies in humans.

Authors:  T Muryoi; T Sasaki; N Harata; O Takai; E Tamate; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

9.  Anti-idiotypic induced suppression of Sjögren's syndrome associated anti-La autoantibody secretion in vitro.

Authors:  A C Horsfall; P A Mumford; P J Venables; R N Maini
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

10.  An idiotypic complementarity between rheumatoid factor and anti-peptidoglycan antibodies?

Authors:  P M Johnson; K K Phua; H B Evans
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.